evolut
oversight
framework
asilomar
beyond
nih
guidelin
dynam
oversight
framework
nih
guidelin
today
ibc
linchpin
framework
biosafeti
oversight
current
scope
respons
import
partnership
promot
ibc
excel
nih
role
support
ibc
nih
ibc
site
visit
program
lesson
learn
site
visit
program
impact
site
visit
program
institut
role
support
ibc
futur
face
ibc
introduct
recombin
dna
transform
technolog
provid
tool
enabl
tremend
understand
life
fundament
level
also
led
myriad
medic
agricultur
applic
progress
recombin
dna
research
continu
revolution
approach
life
scienc
research
biotechnolog
possibl
scientist
take
lead
develop
technolog
foresight
recogn
promis
recombin
dna
could
realiz
assum
respons
address
safeti
ethic
concern
rais
current
system
oversight
recombin
dna
research
establish
almost
year
ago
nih
guidelin
research
involv
recombin
synthet
nucleic
acid
molecul
nih
guidelin
first
written
feder
level
nih
guidelin
initi
administ
offic
recombin
dna
activ
orda
later
becam
offic
biotechnolog
activ
oba
within
offic
scienc
polici
nih
guidelin
outlin
requir
local
oversight
includ
establish
institut
oversight
committe
first
nih
guidelin
articul
requir
institut
biohazard
committe
later
renam
institut
biosafeti
committe
ibc
clearli
reflect
role
ibc
must
review
recombin
synthet
nucleic
acid
molecul
research
conform
nih
guidelin
addit
assess
research
potenti
risk
health
environ
accomplish
review
physic
biolog
contain
research
ensur
research
adequ
train
conduct
research
propos
safe
hallmark
oversight
system
incept
public
particip
transpar
attent
concern
commun
local
interest
major
theme
carri
forward
system
biosafeti
oversight
today
key
element
serv
preserv
public
trust
safeti
life
scienc
research
enterpris
retrospect
risk
recombin
dna
technolog
fear
earli
evolut
materi
fact
notwithstand
develop
scientif
base
oversight
system
ibc
centerpiec
permit
safe
develop
recombin
dna
essenti
technolog
research
year
oversight
ibc
proven
critic
import
ensur
safeti
throughout
variou
research
field
medic
occup
environment
well
promot
respons
scientif
practic
due
dynam
natur
life
scienc
remain
ongo
need
assess
biosafeti
dimens
research
conduct
manag
risk
associ
work
life
scienc
research
continu
advanc
mani
line
research
particularli
involv
highli
pathogen
organ
continu
gener
public
concern
financi
support
life
scienc
research
come
primarili
publicli
deriv
tax
dollar
life
scienc
commun
must
demonstr
public
respons
steward
fund
ibc
today
remain
critic
import
preserv
public
trust
thu
facilit
continu
scientif
progress
nation
institut
health
nih
institut
fund
must
continu
ensur
ibc
equip
fulfil
respons
biosafeti
risk
respons
manag
public
safeti
trust
preserv
landmark
asilomar
confer
involv
lead
scientist
varieti
disciplin
launch
develop
becom
endur
system
institut
feder
oversight
research
util
recombin
dna
technolog
guid
nih
advent
recombin
dna
techniqu
earli
debat
aros
scientif
commun
regard
potenti
health
environment
risk
genet
manipul
organ
public
also
becam
involv
debat
concern
danger
emerg
recombin
dna
technolog
led
scientif
commun
call
unpreced
voluntari
moratorium
certain
experi
recombin
dna
risk
could
character
procedur
develop
minim
risk
scientist
call
format
nation
oversight
bodi
ensur
public
discuss
ongo
oversight
emerg
technolog
one
outcom
process
format
nation
institut
health
recombin
recombin
dna
nascent
poorli
understood
technolog
emerg
import
tool
conduct
biomed
research
public
apprehens
novel
technolog
relat
potenti
impact
environ
public
health
well
host
ethic
social
issu
due
capac
modifi
molecular
centerpiec
life
debat
safeti
captur
congression
attent
result
dozen
legisl
propos
would
statutorili
impos
number
restrict
develop
use
technolog
number
local
jurisdict
also
consid
similar
ordin
would
preclud
use
recombin
dna
altogeth
notabl
among
citi
cambridg
massachusett
becam
first
jurisdict
unit
state
directli
regul
basic
scientif
research
use
recombin
dna
cambridg
recombin
dna
technolog
ordin
also
establish
strict
oversight
univers
commerci
laboratori
engag
recombin
dna
research
requir
set
forth
citi
ordin
base
nih
guidelin
cambridg
biosafeti
committe
carri
enforc
committe
staf
cambridg
public
health
depart
compris
cambridg
resid
still
oper
day
initi
version
nih
guidelin
draft
rac
year
asilomar
confer
unlik
statut
contempl
nih
guidelin
intend
live
document
detail
requir
biosafeti
practic
institut
investig
follow
conson
current
scientif
understand
design
nih
guidelin
dynam
document
maintain
relev
evolv
along
scienc
technolog
undergon
multipl
revis
sinc
almost
immedi
complet
first
iter
nih
guidelin
thendepart
health
educ
welfar
depart
health
human
servic
held
nation
confer
take
fresh
look
state
understand
risk
pose
recombin
dna
technolog
time
rac
review
everi
singl
recombin
dna
protocol
conduct
nih
decid
rac
review
protocol
well
restrict
field
research
outlin
first
iter
nih
guidelin
longer
necessari
instead
transpar
provis
oversight
system
public
access
institut
review
process
enhanc
substitut
diminish
role
rac
protocol
review
toward
end
sever
revis
made
nih
guidelin
includ
significantli
increas
public
access
inform
recombin
dna
research
activ
public
particip
administr
nih
guidelin
local
commun
nih
guidelin
origin
requir
less
ibc
would
compris
member
affili
institut
posit
repres
commun
interest
chang
nih
guidelin
elimin
less
claus
instead
requir
least
two
ibc
member
affili
institut
posit
repres
commun
interest
furthermor
import
record
ibc
includ
minut
memoranda
understand
agreement
registr
document
materi
submit
feder
govern
made
avail
public
upon
request
earli
mani
observ
field
recombin
dna
research
prescient
enough
forese
eventu
applic
human
among
coalit
religi
leader
ask
presid
reagan
commiss
studi
ethic
problem
biomed
behavior
research
group
set
look
ethic
human
subject
research
undertak
special
topic
genet
engin
human
result
analysi
report
splice
life
social
ethic
issu
genet
engin
human
be
report
convey
rac
consider
led
rac
recommend
number
chang
nih
guidelin
went
effect
april
includ
give
ibc
formal
mandat
review
approv
human
gene
transfer
hgt
research
subsequ
document
titl
point
consid
design
submiss
gene
therapi
trial
nih
develop
rac
incorpor
nih
guidelin
appendix
outlin
ibc
kind
matter
expect
evalu
review
propos
administr
recombin
dna
human
subject
clinic
trial
time
substanti
advanc
hgt
coincid
first
gene
transfer
trial
approv
nih
director
unit
state
depart
agricultur
usda
raclik
bodi
known
agricultur
biotechnolog
research
advisori
committe
abrac
process
develop
contain
guidelin
agricultur
research
take
place
outsid
context
laboratorysuch
greenhous
larg
anim
facil
nih
consult
feder
exofficio
member
rac
determin
would
make
sens
consolid
requir
concern
contain
recombin
dna
nih
guidelin
consequ
usda
guidelin
incorpor
nih
guidelin
appendic
p
plant
q
anim
addit
appendic
also
includ
modif
ibc
membership
requir
ensur
appropri
expertis
exist
ibc
institut
conduct
type
research
also
prove
time
introspect
nih
regard
recombin
dna
oversight
especi
realm
hgt
research
becom
lead
matter
brought
rac
nih
director
time
call
thorough
analysi
invest
nih
make
field
hgt
research
optim
mechan
nih
oversight
field
accomplish
effort
two
committe
orkinmotulski
committe
look
question
nih
invest
field
conclud
field
still
great
promis
progress
hamper
gap
scientif
knowledg
committe
urg
nih
fund
proportion
basic
research
build
stronger
scientif
foundat
would
inform
clinic
scienc
verma
committe
look
optim
valu
rac
conclud
necessari
rac
publicli
review
everi
protocol
submit
nih
necessari
nih
approv
everi
protocol
ibc
bodi
institut
review
board
irb
food
drug
administr
fda
approv
author
rac
process
could
optim
valu
mean
inform
deliber
group
consequ
recommend
rac
review
public
protocol
rais
special
novel
scientif
safeti
ethic
issu
recommend
verma
committe
embodi
octob
revis
nih
guidelin
elimin
need
nih
approv
hgt
trial
nih
guidelin
continu
updat
sinc
address
variou
issu
hgt
basic
laboratori
research
last
major
chang
nih
guidelin
occur
amend
specif
cover
certain
basic
clinic
research
nucleic
acid
molecul
creat
sole
synthet
mean
time
like
research
synthet
nucleic
acid
also
involv
use
recombin
techniqu
thu
alreadi
cover
nih
guidelin
howev
chang
design
forwardlook
recogn
new
technolog
rapidli
expand
amend
nih
guidelin
also
made
clear
focu
biosafeti
review
new
genet
construct
focu
product
techniqu
use
produc
reflect
chang
name
nih
guidelin
chang
nih
guidelin
research
involv
recombin
synthet
nucleic
acid
molecul
nih
guidelin
never
complet
imposs
forese
futur
advanc
scienc
therefor
import
involv
conduct
oversight
research
adher
specif
nih
guidelin
also
intent
spirit
document
dynam
natur
nih
guidelin
serv
promot
comprehens
oversight
field
continu
advanc
much
flexibl
manner
statutori
framework
could
permit
scienc
proceed
safe
respons
manner
current
nih
guidelin
appli
research
conduct
sponsor
institut
receiv
nih
fund
recombin
synthet
nucleic
acid
molecul
research
howev
nih
guidelin
reachthrough
provis
institut
receiv
nih
fund
project
involv
recombin
synthet
nucleic
acid
molecul
research
involv
recombin
synthet
nucleic
acid
molecul
conduct
sponsor
institut
even
nihfund
becom
subject
requir
nih
guidelin
logic
broad
applic
nih
guidelin
effect
system
oversight
observ
research
given
institut
thu
nih
guidelin
becom
univers
standard
safe
scientif
practic
recombin
synthet
nucleic
acid
molecul
research
mani
privat
entiti
feder
agenc
institut
also
follow
nih
guidelin
voluntarili
even
though
otherwis
subject
requir
nih
guidelin
term
guidelin
establish
principl
basic
safeti
practic
document
articul
perform
standard
without
unduli
prescript
titl
document
meant
convey
howev
nih
guidelin
option
requir
abid
nih
guidelin
term
condit
nih
fund
research
subject
scope
noncompli
nih
guidelin
could
result
suspens
termin
nih
fund
research
recombin
synthet
nucleic
acid
molecul
requir
project
subject
nih
guidelin
institut
receiv
prior
nih
approv
time
nih
guidelin
permit
great
deal
flexibl
particularli
implement
administr
aspect
research
oversight
enabl
institut
tailor
program
meet
specif
need
respons
institut
establish
implement
polici
safe
conduct
research
subject
nih
guidelin
key
part
respons
establish
ibc
receipt
nih
fund
recombin
synthet
nucleic
acid
molecul
research
come
requir
institut
establish
ibc
ibc
must
compos
least
five
individu
collect
appropri
expertis
abl
review
research
conduct
institut
includ
plant
anim
biosafeti
expert
applic
addit
scientif
expertis
member
ibc
knowledg
biosafeti
physic
contain
principl
understand
institut
safeti
polici
institut
must
appoint
biolog
safeti
offic
bso
serv
ibc
institut
conduct
high
contain
recombin
synthet
nucleic
acid
research
ie
biosafeti
level
largescal
research
ie
use
cultur
greater
ten
liter
aggreg
volum
least
two
member
ibc
must
affili
institut
repres
commun
interest
requir
two
nonaffili
member
deriv
core
principl
nih
system
oversight
ibc
review
oversight
transpar
involv
public
particip
nih
guidelin
ibc
respons
local
oversight
recombin
synthet
nucleic
acid
molecul
research
although
respons
need
restrict
research
review
propos
experi
ensur
conduct
manner
consist
biosafeti
practic
outlin
nih
guidelin
respect
hgt
trial
ibc
addit
respons
appendix
nih
guidelin
review
protocol
ensur
safe
proper
design
research
includ
analysi
advers
event
report
find
anim
studi
german
design
conduct
human
studi
accordingli
specif
ibc
respons
articul
nih
guidelin
includ
review
research
conduct
sponsor
institut
complianc
nih
guidelin
review
requir
differ
level
evalu
depend
natur
work
help
investig
determin
appropri
contain
condit
conduct
research
ibc
recommend
guid
one
sever
appendic
nih
guidelin
specifi
safeti
contain
practic
variou
form
research
subject
document
assess
adequaci
facil
institut
procedur
practic
investig
train
expertis
type
research
conduct
period
review
research
conduct
institut
ensur
ongo
complianc
adopt
emerg
plan
cover
accident
spill
personnel
contamin
result
research
activ
report
signific
problem
violat
regul
signific
researchrel
accid
ill
appropri
institut
offici
relev
feder
entiti
ensur
investig
laboratori
staff
adequ
train
conduct
propos
work
safe
incumb
upon
feder
funder
research
institut
conduct
work
ensur
ibc
well
posit
serv
pivot
role
uphold
biosafeti
standard
practic
therebi
sustain
public
trust
life
scienc
research
enterpris
institut
level
mean
robust
wellrun
biolog
safeti
program
heart
program
ibc
support
ibc
promot
import
biosafeti
level
individu
research
way
senior
level
institut
administr
share
respons
nih
research
commun
must
work
togeth
toward
ensur
optim
function
ibc
nih
made
prioriti
develop
program
outreach
educ
multifacet
use
multipl
modal
commun
ibc
element
institut
infrastructur
key
respons
uphold
biosafeti
principl
practic
nih
guidelin
nih
outreach
program
extens
includ
give
present
brief
major
nation
region
scientif
confer
profession
develop
meet
key
stakehold
group
complianc
nih
guidelin
outreach
staff
develop
conduct
individu
workshop
train
session
educ
nih
system
oversight
recombin
synthet
nucleic
acid
molecul
research
nih
guidelin
target
audienc
includ
investig
ibc
member
staff
bso
industri
repres
institut
complianc
offici
particular
note
nihdevelop
support
nation
train
cours
ibc
basic
effect
ibc
provid
indepth
inform
establish
run
effect
compliant
ibc
program
addit
nih
also
host
ibc
profession
develop
confer
seri
biannual
event
nation
profession
develop
forum
member
staff
ibc
nih
also
develop
array
electron
print
educ
materi
includ
train
present
institut
tailor
need
set
frequent
ask
question
biosafeti
guidanc
tool
mani
topic
interest
institut
subject
nih
guidelin
brochur
investig
respons
poster
promot
awar
biosafeti
biosecur
polici
novemb
nih
launch
ibc
site
visit
program
program
essenti
element
nih
outreach
activ
sinc
offer
tailor
interact
experi
provid
forum
institut
ask
question
nih
guidelin
enabl
make
inform
enhanc
ibc
program
incorpor
best
practic
remedi
defici
date
nih
visit
divers
set
institut
includ
univers
medic
school
research
institut
commerci
entiti
conduct
vari
type
research
program
rang
emphasi
basic
biomed
agricultur
program
clinic
research
addit
help
institut
improv
program
immedi
term
program
aim
assist
ibc
commun
longer
term
identifi
common
challeng
face
institut
purpos
custom
nih
educ
program
assist
institut
overcom
develop
bodi
best
practic
institut
may
consid
appropri
optim
function
program
creat
selfevalu
tool
institut
use
assess
improv
ibc
program
one
major
goal
site
visit
program
develop
bodi
inform
could
share
ibc
commun
eye
toward
enhanc
ibc
function
number
common
featur
practic
observ
institut
particularli
wellrun
effect
program
ibc
charter
wellwritten
sop
foster
develop
consist
wellrun
compliant
biosafeti
program
document
defin
author
ibc
outlin
oper
review
practic
describ
protocol
registr
requir
investig
must
follow
keep
ibc
member
investig
alik
inform
biosafeti
standard
review
requir
must
observ
institut
ibc
simpli
respons
approv
research
also
ensur
ongo
safe
conduct
research
nih
guidelin
ibc
must
conduct
period
review
research
involv
recombin
dna
nih
guidelin
prescrib
frequenc
review
natur
biosafeti
profil
research
involv
recombin
dna
extrem
divers
ibc
must
make
judgment
appropri
frequenc
revisit
ongo
work
nih
guidelin
place
great
deal
emphasi
train
educ
institut
respons
ensur
train
everyon
involv
conduct
oversight
recombin
dna
research
conduct
train
also
respons
bso
pi
clear
understand
biosafeti
practic
individu
respons
articul
nih
guidelin
pivot
effect
biosafeti
program
committe
minut
critic
import
number
reason
first
creat
institut
memori
creat
record
committe
decisionmak
turn
foster
consist
research
review
second
document
ibc
fulfil
respons
nih
guidelin
final
part
transpar
foster
nih
guidelin
ibc
must
make
meet
minut
avail
public
upon
request
provid
import
view
institut
safeti
practic
sinc
incept
strong
evid
nih
site
visit
program
enhanc
effect
institut
biosafeti
program
hackney
et
al
present
result
survey
conduct
examin
trend
ibc
practic
author
compar
result
similar
survey
conduct
result
survey
show
ibc
made
signific
improv
sinc
level
staf
support
conduc
train
increas
transpar
public
overal
complianc
nih
guidelin
primari
reason
cite
author
improv
ibc
perform
nih
site
visit
program
institut
respond
survey
state
believ
nih
site
visit
enhanc
institut
oversight
recombin
synthet
nucleic
acid
molecul
research
result
survey
also
show
institut
undergon
site
visit
better
pois
effect
carri
respons
nih
guidelin
institut
site
visit
attribut
awarenessrais
natur
nih
site
visit
program
exampl
survey
found
institut
site
visit
report
incid
involv
signific
problem
violat
nih
guidelin
signific
researchrel
accid
ill
nih
nonsitevisit
institut
report
incid
requir
nih
guidelin
similarli
respond
receiv
site
visit
pi
train
place
wherea
institut
site
visit
similar
train
nih
note
incid
report
complianc
increas
site
visit
import
incid
report
strongli
emphas
site
visit
enhanc
institut
complianc
requir
nih
guidelin
may
also
attribut
institut
util
institut
biosafeti
committe
selfassess
tool
nih
first
issu
selfassess
tool
revis
tool
aim
tool
twofold
first
quickli
realiz
nih
would
abl
perform
site
visit
regist
ibc
selfassess
tool
creat
encourag
institut
assess
program
use
perform
indic
nih
visit
tool
consist
core
question
relat
specif
requir
nih
guidelin
tool
pose
question
list
citat
nih
guidelin
pertin
provid
nih
guidanc
requir
address
institut
tool
also
contain
nih
recommend
number
best
practic
specif
articul
requir
nih
guidelin
nonetheless
could
enhanc
effect
ibc
nih
guidelin
articul
number
respons
institut
conduct
research
subject
scope
document
includ
establish
implement
polici
provid
safe
conduct
research
effect
carri
function
essenti
ibc
receiv
full
support
collabor
senior
institut
offici
ibc
must
author
fulfil
respons
properli
ibc
approv
research
also
may
reject
propos
activ
shut
ongo
research
concern
activ
meet
biosafeti
standard
articul
nih
guidelin
ibc
must
back
senior
institut
administr
exert
author
meaning
ibc
need
suffici
staf
resourc
properli
fulfil
respons
one
benchmark
consid
number
protocol
review
annual
irb
institut
anim
care
use
committe
iacuc
ibc
consid
whether
resourc
accord
committe
proport
respect
workload
addit
ibc
protocol
review
approv
respons
ibc
biosafeti
program
staff
conduct
train
laboratori
inspect
ongo
oversight
research
research
portfolio
expand
institut
also
period
conduct
thorough
assess
resourc
necessari
program
effect
fulfil
role
respons
articul
nih
guidelin
take
account
respons
institut
ibc
biosafeti
staff
nih
continu
provid
outreach
educ
resourc
assist
institut
encourag
institut
take
rigor
ongo
examin
ibc
program
although
mani
fear
impact
recombin
dna
technolog
come
pass
mani
aspect
life
scienc
research
continu
warrant
review
oversight
pace
scientist
bring
chang
biolog
system
everincreas
experi
took
week
month
complet
year
ago
perform
day
even
hour
time
increasingli
interdisciplinari
research
conduct
life
scienc
technolog
employ
area
materi
scienc
chemic
engin
synthet
biolog
prime
exampl
combin
method
principl
knowledg
disciplin
includ
biolog
engin
mathemat
comput
scienc
thu
ibc
almost
certainli
face
review
increasingli
novel
protocol
interdisciplinari
realm
addit
conduct
risk
assess
import
respons
ibc
ensur
conduct
research
experi
train
conduct
research
safe
like
scientist
educ
field
tradit
life
scienc
disciplin
may
comprehens
biosafeti
train
may
unfamiliar
potenti
risk
best
manag
instanc
particularli
import
ibc
ensur
risk
research
evalu
rigor
possibl
research
involv
appropri
train
scientist
recent
develop
sever
new
genet
engin
tool
includ
genom
edit
technolog
crispr
talen
zinc
finger
nucleas
new
tool
capabl
may
transform
biolog
research
benefit
human
heath
agricultur
industri
environ
mani
new
technolog
may
pose
minim
biosafeti
risk
emerg
technolog
rais
uncertainti
environment
safeti
effect
human
health
incumb
conduct
overse
research
ensur
potenti
risk
evalu
manag
necessari
datadriven
risk
assess
commensur
oversight
key
demonstr
life
scienc
commun
continu
uphold
cultur
respons
ensur
scienc
proce
safe
nih
ask
american
societi
gene
cell
therapi
profession
organ
scientist
conduct
hgt
research
review
role
rac
determin
whether
indepth
individu
review
everi
hgt
protocol
still
warrant
given
state
scienc
mani
year
conduct
trial
whether
scientif
safeti
ethic
concern
continu
justifi
special
level
oversight
area
research
review
carri
part
nih
ongo
evalu
oversight
framework
gene
transfer
recombin
dna
research
nih
director
commiss
institut
medicin
iom
establish
independ
committe
specif
look
question
whether
hgt
research
rais
issu
concern
warrant
extra
oversight
rac
form
review
individu
clinic
protocol
oversight
warrant
recommend
criteria
guid
rac
review
research
report
oversight
review
clinic
gene
transfer
protocol
assess
role
recombin
dna
advisori
committe
iom
committe
conclud
although
gene
transfer
research
continu
rais
import
scientif
social
ethic
question
gene
transfer
research
novel
enough
controversi
enough
justifi
current
form
addit
oversight
nation
level
committe
also
recommend
individu
protocol
continu
regist
nih
protocol
subject
public
review
rac
except
except
circumst
specif
iom
recommend
individu
gene
transfer
protocol
review
rac
restrict
situat
protocol
review
could
adequ
perform
regulatori
oversight
process
exampl
ibc
irb
iom
report
state
protocol
continu
regist
nih
review
advers
event
protocol
continu
evalu
trend
may
lead
greater
awar
safeti
concern
nih
care
consid
accept
iom
recommend
rac
review
hgt
research
iom
recommend
implement
protocol
continu
regist
nih
indepth
public
rac
review
individu
gene
transfer
protocol
limit
except
case
ibc
oversight
bodi
may
need
assist
review
except
novel
protocol
nih
like
continu
provid
key
inform
protocol
includ
evolut
design
detail
product
use
augment
institut
review
bodi
resourc
infecti
diseas
signific
caus
mortal
morbid
diarrheal
diseas
malaria
tuberculosi
influenza
exact
huge
toll
human
health
addit
exot
pathogen
associ
high
morbid
mortal
human
frequent
emerg
recent
exampl
highli
lethal
middl
east
respiratori
syndrom
coronaviru
emerg
nih
nation
institut
allergi
infecti
diseas
niaid
research
portfolio
expand
consider
recent
year
respons
new
challeng
biodefens
emerg
reemerg
infecti
diseas
research
pathogen
diseas
vital
import
design
appropri
medic
countermeasur
form
diagnost
therapi
vaccin
research
particularli
work
conduct
high
maximum
contain
laboratori
frequent
scrutin
term
potenti
risk
pose
public
laboratori
accid
intent
misus
nih
guidelin
requir
ibc
establish
specif
review
research
involv
recombin
synthet
nucleic
acid
molecul
ibc
respons
ensur
research
activ
perform
appropri
biosafeti
precaut
howev
expertis
mani
institut
assign
committe
addit
author
may
includ
oversight
research
involv
biohazard
materi
nonrecombin
infecti
agent
guidanc
document
cdcnih
public
biosafeti
microbiolog
biomed
laboratori
bmbl
suggest
ibc
broader
purview
determin
appropri
biosafeti
level
experi
pathogen
agent
survey
ibc
indic
vast
major
ibc
fact
broader
purview
assign
specif
nih
guidelin
mani
academ
institut
invest
highcontain
laboratori
facil
research
portfolio
expand
arena
highli
pathogen
diseas
becom
ever
import
ibc
pois
ensur
research
conduct
safe
possibl
welltrain
research
staff
use
robust
standard
oper
procedur
wellmaintain
facil
life
scienc
research
vital
improv
public
health
agricultur
environ
strengthen
nation
secur
economi
yet
research
design
find
way
better
health
welfar
safeti
humankind
also
yield
inform
technolog
could
potenti
misus
harm
purpos
instanc
inform
certain
life
scienc
research
could
misappli
weapon
danger
pathogen
bypass
diminish
effect
medic
countermeasur
threaten
way
health
safeti
human
anim
plant
environ
research
yield
new
technolog
inform
potenti
benevol
malevol
applic
refer
dual
use
research
dual
use
potenti
certain
life
scienc
research
recogn
import
biosecur
issu
number
year
degre
dual
use
potenti
may
inher
signific
portion
life
scienc
research
howev
small
subset
life
scienc
research
highest
potenti
yield
knowledg
product
technolog
could
misappli
threaten
public
health
nation
secur
refer
dual
use
research
concern
us
govern
usg
defin
dual
use
research
concern
life
scienc
research
base
current
understand
reason
anticip
provid
knowledg
inform
product
technolog
could
directli
misappli
pose
signific
threat
broad
potenti
consequ
public
health
safeti
agricultur
crop
plant
anim
environ
materiel
nation
secur
vital
import
research
institut
vigil
respect
dual
use
potenti
life
scienc
research
carri
septemb
usg
issu
polici
institut
oversight
life
scienc
dual
use
research
concern
polici
requir
research
institut
establish
process
identifi
dual
use
research
concern
articul
formal
role
respons
institut
investig
conduct
research
support
feder
govern
fall
scope
polici
aim
preserv
benefit
life
scienc
research
minim
risk
knowledg
inform
product
technolog
gener
research
could
use
manner
result
harm
institut
subject
polici
requir
establish
implement
intern
polici
practic
provid
identif
effect
oversight
dual
use
research
concern
key
respons
establish
institut
review
entiti
ire
execut
requir
polici
polici
state
rang
mechan
fulfil
role
ire
accept
long
review
entiti
appropri
constitut
author
institut
conduct
dual
use
review
like
mani
instanc
institut
choos
util
ibc
perform
function
ire
nih
feder
govern
agenc
conduct
support
life
scienc
research
develop
number
resourc
assist
ire
review
research
potenti
dual
use
research
concern
conclus
year
asilomar
ibc
continu
play
relev
vital
role
life
scienc
oversight
system
proven
key
compon
biosafeti
manag
research
activ
today
understand
recombin
dna
technolog
attend
risk
far
greater
although
mani
initi
fear
technolog
turn
unfound
remain
need
vigil
mani
aspect
research
enterpris
capabl
life
scienc
advanc
rapidli
past
four
decad
capac
manipul
organ
like
continu
advanc
similar
acceler
pace
forese
futur
scientif
commun
long
demonstr
cultur
respons
ensur
safeti
research
public
environ
must
also
remain
cogniz
potenti
risk
emerg
technolog
manag
accordingli
public
continu
pointedli
concern
mani
aspect
life
scienc
research
especi
context
human
studi
research
involv
infecti
agent
public
continu
support
biomed
research
trust
endeavor
may
fragil
ibc
central
transpar
demonstr
abil
scientif
commun
serv
respons
steward
publicli
fund
research
help
earn
preserv
trust
place
